SG Americas Securities LLC Boosts Position in Envista Holdings Corporation $NVST

SG Americas Securities LLC lifted its position in Envista Holdings Corporation (NYSE:NVST) by 141.0% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 41,782 shares of the company’s stock after purchasing an additional 24,446 shares during the quarter. SG Americas Securities LLC’s holdings in Envista were worth $851,000 at the end of the most recent reporting period.

A number of other institutional investors also recently bought and sold shares of the company. Farther Finance Advisors LLC grew its stake in shares of Envista by 317.6% in the 3rd quarter. Farther Finance Advisors LLC now owns 1,349 shares of the company’s stock valued at $27,000 after buying an additional 1,026 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its holdings in Envista by 73.1% in the second quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 2,248 shares of the company’s stock valued at $44,000 after acquiring an additional 949 shares during the last quarter. SJS Investment Consulting Inc. grew its position in Envista by 10,356.5% in the third quarter. SJS Investment Consulting Inc. now owns 2,405 shares of the company’s stock worth $49,000 after acquiring an additional 2,382 shares during the period. EverSource Wealth Advisors LLC increased its stake in Envista by 378.0% during the second quarter. EverSource Wealth Advisors LLC now owns 2,414 shares of the company’s stock worth $47,000 after acquiring an additional 1,909 shares during the last quarter. Finally, GAMMA Investing LLC increased its stake in Envista by 34.3% during the third quarter. GAMMA Investing LLC now owns 2,498 shares of the company’s stock worth $51,000 after acquiring an additional 638 shares during the last quarter.

Wall Street Analysts Forecast Growth

A number of research firms have recently weighed in on NVST. Mizuho set a $19.00 price target on Envista in a report on Monday, November 3rd. Robert W. Baird set a $27.00 target price on shares of Envista in a research note on Friday, October 31st. Stifel Nicolaus set a $25.00 price target on shares of Envista in a research report on Thursday, October 30th. JPMorgan Chase & Co. boosted their price target on shares of Envista from $20.00 to $22.00 and gave the company a “neutral” rating in a research note on Tuesday, December 16th. Finally, Weiss Ratings reaffirmed a “sell (d)” rating on shares of Envista in a research report on Monday, December 29th. One equities research analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating, eight have given a Hold rating and two have given a Sell rating to the company’s stock. Based on data from MarketBeat, Envista currently has a consensus rating of “Hold” and an average target price of $21.77.

Envista Stock Up 2.2%

Shares of NVST opened at $25.24 on Tuesday. The company’s 50-day simple moving average is $21.59 and its 200-day simple moving average is $20.82. The company has a debt-to-equity ratio of 0.47, a quick ratio of 2.02 and a current ratio of 2.37. Envista Holdings Corporation has a 1 year low of $14.22 and a 1 year high of $25.41. The stock has a market capitalization of $4.15 billion, a PE ratio of 280.48, a P/E/G ratio of 1.13 and a beta of 0.99.

Envista (NYSE:NVST) last announced its earnings results on Wednesday, October 29th. The company reported $0.32 earnings per share for the quarter, topping the consensus estimate of $0.27 by $0.05. The firm had revenue of $669.90 million for the quarter, compared to the consensus estimate of $639.49 million. Envista had a net margin of 0.58% and a return on equity of 5.90%. The firm’s revenue for the quarter was up 11.5% on a year-over-year basis. During the same period in the prior year, the firm earned $0.12 EPS. Analysts forecast that Envista Holdings Corporation will post 1 earnings per share for the current fiscal year.

About Envista

Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.

Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.